Pharmaceutical polyacrylonitrile fiber for preventing and curing mammary gland hyperplasia, preparation and application thereof
A polyacrylonitrile fiber and mammary gland hyperplasia technology, which is applied in the field of medicinal fibers, can solve problems such as strong odor, and achieve the effects of simple production process, abundant raw material sources, and easy realization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] The first step is to prepare spinning dope. Firstly, a spinning dope containing polyacrylonitrile was prepared according to an existing process, wherein the dry solid content A of polyacrylonitrile was 99 parts by weight. Then the medicine for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator are added in the spinning stock solution and stirred evenly. The solid content C is 0.5 parts by weight;
[0026] In the second step, the spinning stock solution containing the anti-mammary gland hyperplasia drug and the drug transdermal absorption accelerator is made into medicinal polyacrylonitrile fiber, and the wet spinning process, the dry spinning process or the dry jet wet spinning process can be used , the prepared medicinal polyacrylonitrile fiber not only contains polyacrylonitrile, but also contains drugs for preventing and treating mammary gland hyperplasia and drug transdermal absorption accelerators;
[0027] The prepa...
Embodiment 2
[0033] In the present embodiment, the dry solid content A of polyacrylonitrile in the spinning dope is 80 parts by weight, the dry solid content B of the drug for preventing and treating mammary gland hyperplasia is 15 parts by weight, and the dry solid content C of the drug transdermal absorption accelerator is 5 parts by weight Parts, other methods are the same as in Example 1.
Embodiment 3
[0035] In the present embodiment, the dry solid content A of polyacrylonitrile in the spinning dope is 70 parts by weight, the dry solid content B of the drug for preventing and treating mammary gland hyperplasia is 20 parts by weight, and the dry solid content C of the drug transdermal absorption accelerator is 10 parts by weight Parts, other methods are the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com